| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | dinaciclib | CTRPv2 | pan-cancer | AAC | -0.022 | 0.6 |
| mRNA | BRD-K27188169 | CTRPv2 | pan-cancer | AAC | -0.025 | 0.6 |
| mRNA | CAY10576 | CTRPv2 | pan-cancer | AAC | 0.018 | 0.6 |
| mRNA | tamatinib | CTRPv2 | pan-cancer | AAC | -0.017 | 0.6 |
| mRNA | etoposide | GDSC1000 | pan-cancer | AAC | 0.016 | 0.6 |
| mRNA | GW-2580 | GDSC1000 | pan-cancer | AAC | -0.016 | 0.6 |
| mRNA | Talazoparib | GDSC1000 | pan-cancer | AAC | 0.015 | 0.6 |
| mRNA | BIRB 0796 | FIMM | pan-cancer | AAC | 0.084 | 0.6 |
| mRNA | GSK2126458 | GDSC1000 | pan-cancer | AAC | 0.014 | 0.6 |
| mRNA | navitoclax:piperlongumine (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.016 | 0.6 |